|Date||Speaker(s)||Presentation Title Sorted by ascending order, click header to sort descending|
Brian M. Rivers, Ph.D., M.P.H.
|A Community-based Translational Research Framework to Address Prostate Cancer Disparities|
Louise M. Henderson, Ph.D.
|Advancing a Risk-based Approach for Cancer Screening|
Ernest Hawk, M.D., M.P.H.
|Advancing Cancer Prevention & Control As Plan A: Perspectives from a Former Cancer Prevention Fellow|
Ann Hsing, Ph.D., M.P.H.
|A Fantastic Epidemiology Journey: from China to Africa and back|
Douglas L. Weed, M.D., Ph.D., M.P.H.
|After the NCI: Methods, Mountains, and Mischief|
Noelle J. LoConte, M.D.
|Alcohol and Cancer: A Call to Action for the Oncology Community|
Joel Palefsky, M.D.
|Anal HPV Infection and Disease: A Model for Understanding All Things HPV|
John F. McDonald, Ph.D.
|An Integrated Approach to Ovarian Cancer Diagnostics and Personalized Therapy|
Ian Barron, Ph.D.
|Aspirin & Breast Cancer — Adjuvant Treatment & Mechanisms of Action|
Andrew Chan, M.D., M.P.H.
|Aspirin for the Precision Prevention of Colorectal Cancer|
Patti E. Gravitt, Ph.D., M.S.
|A Systems Practice Approach to Sustainable Implementation of HPV-based Screening in the Peruvian Amazon|
Lisa Carter-Harris, Ph.D.
|Beyond a Closed-Ended Question: Understanding the Decision to Screen or Not for Lung Cancer|
Erin Costanzo, Ph.D.
|BioBehavioral Influences on Recovery Following Hematopoietic Stem Cell Transplantation|
John D. Groopman, Ph.D.
|Biomarkers for Etiology and Prevention of Liver Cancer: Second Leading Cause of Global Cancer Mortality|
Kathleen Arcaro, Ph.D.
|Biomarkers of Breast Cancer Risk in Breast Milk|
Ashwani Rajput, M.D.
|Building Bridges to Enhance Cancer Prevention and Care|
Ali H. Mokdad, Ph.D.
|Burden of Cancer in the United States: Findings from the Global Burden of Disease|
Patricia Ganz, M.D.
|Cancer and Aging: Implications for Cancer Survivors|
Hazel B. Nichols, Ph.D.
|Cancer and Parenthood|
Ulrike Boehmer, Ph.D.
|Cancer and the LGBT Community: Reporting on an Understudied Population|
Scarlett Lin Gomez, Ph.D., M.P.H.
|Cancer Health Disparities Research: Where have we been and where should we go?|
Jim Evans, M.D., Ph.D.
|Cancer Prevention, Genomics, and the PMI|
Timothy R. Rebbeck, Ph.D.
|Cancer Prevention in the Precision Medicine Era|
Jessica Faupel-Badger, Ph.D.
|Careers in cancer prevention research - Reflections from a large outcomes evaluation study|
Barbara S. Norquist, M.D.
|Challenges in the Clinical Management of Women at Risk for Ovarian Cancer|
Daniel A. Rodríguez, Ph.D., M.S.T.
|Commute Patterns and Depression: Evidence from Eleven Latin American Cities|
Andrew Briggs, D.Phil., M.Sc.
|Designing a value framework for oncology: what are the issues with existing frameworks and can we do better?|
Judith Prochaska, Ph.D., M.P.H.
|Digital Tools for Cancer Prevention: Extending Reach and Engagement|
Ilona Jaspers, Ph.D., M.S.
|E-cigarettes and Vaping: Toxicities, Misconceptions, and Health Effects|
Jeff Niederdeppe, Ph.D.
|Effects of Tobacco Product Warning Labels on Youth and Adults: Broader Implications for Cancer Communication|